| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C0035736> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C0036667> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C0036668> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C0037791> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C1709846> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C3179034> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C3179035> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C5244026> <https://research.tib.eu/covid-19/entity/35118013_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.\', \'Ubiquitome Limited, Auckland, New Zealand.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Pickering_Paul_J> <https://research.tib.eu/covid-19/entity/Thammavongsa_Darani_A> <https://research.tib.eu/covid-19/entity/Turner_Susan_J> <https://research.tib.eu/covid-19/entity/Vega_Noel> <https://research.tib.eu/covid-19/entity/Wyllie_Anne_L> <https://research.tib.eu/covid-19/entity/Yolda-Carr_Devyn>
?:doi	10.3389/fcimb.2021.808773
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fcimb.2021.808773>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Frontiers in cellular and infection microbiology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35118013>
?:pmid	<https://research.tib.eu/covid-19/entity/35118013>
?:pmid	35118013
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.703
?:rankingScore_hIndex	43
?:title	Evaluation of the Liberty16 Mobile Real Time PCR Device for Use With the SalivaDirect Assay for SARS-CoV-2 Testing.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35118013>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35118013>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all